Logo of Herbal Extract
  • Home
  • About Us
  • Categories ▼
    • Reference Substances
    • Botanical Ingredient
    • Standard Herbal Extract
    • ► Hot Product
  • Applications
  • Inquiry
  • FAQ
  • Contact Us
  • Popular Searches:
  • Artemisinin
  • ,
  • Betulinic Acid
  • ,
  • Apigenin
  • ,
  • Arbutin
  • ,
  • Deoxyarbutin
  • ,
  • Diosgenin
  • ,
  • Kaempferol
  • ,
  • Resveratrol
  • ,
  • Green Coffee Bean Extract
  • ,
  • Banaba Leaf Extract
  • ,
  • Loquat Leaves Extract
CATEGORIES
  • Reference Substances

  • Botanical Ingredient

  • Standard Herbal Extract

CONTACT US
  • Contact for herbal and plant extracts
KNOWLEDGE
  • Can Sesamin be an ideal cure to obesity?
  • Berberine for Overall Wholeness and Wellness
  • Artemether Treats Malaria in Both Adults and Children
  • Side Effects and Cautions in Artemisinins Applications
  • Artemisinin Resistance Can Be Defeated By Drug Combinations
Home » Products » Botanical Ingredient » 5-Hydroxytryptophan

5-Hydroxytryptophan

Chemical Structure of 5-Hydroxytryptophan

5-Hydroxytryptophan is extracted from Griffonia simplicifolia. Stanford Chemicals has been providing quality 5-Hydroxytryptophan and many other natural plant extract for over 15 years.

Product Name

5-hydroxytryptophan

CAS No.

4350-09-8

Molecular Formula

C11H12N2O3

Molecular Weight

220.23

Botanical Source

Griffonia simplicifolia

Purity

98%, 99% HPLC

Appearance

Off-white powder

Package

25 kg/drum

Storage

Stored in cool & dry places, protected from direct sunlight and heat.

Shelf Life

2 years

5-Hydroxytryptophan Safety Tips

Handling of 5-Hydroxytryptophan should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.

Related Products
  • Griffonia Seed Extract

    Griffonia Seed Extract
    Griffonia Seed Extract, Specification: 50-99% 5-Hydroxytryptophan HPLC. Botanical Source: Griffonia Simplicifolia.

    inquiry»

References
  • 1. Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders.

    El-Khalili N.Neuropsychiatr Dis Treat. 2012;8:523-36. doi: 10.2147/NDT.S14369. Epub 2012 Nov 8.

  • 2. Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models.

    Kumar B, Jindal A, Pandey DK, Bhatt S, Devadoss T, Mahesh R.Indian J Exp Biol. 2012 Sep;50(9):625-32.

  • 3. Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study.

    Ye J, Yang Y, Yu W, Zou H, Jiang J, Yang R, Shang S, Gu X.J Inherit Metab Dis. 2012 Nov 9. [Epub ahead of print]

  • 4. Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: An investigation in behaviour-based rodent models of depression.

    Mahesh R, Kumar B, Jindal A, Bhatt S, Devadoss T, Pandey DK.Indian J Pharmacol. 2012 Sep;44(5):560-5. doi: 10.4103/0253-7613.100371.

  • 5. 'Sweet Dreams', 'Happy Days' and elevated 24-h urine 5-hydroxyindoleacetic acid excretion.

    Hallin ML, Mahmoud K, Viswanath A, Gama R.Ann Clin Biochem. 2012 Oct 19. [Epub ahead of print]

  • 6. Antidepressant-like effects of the extract from Cimicifuga foetida L.

    Ye L, Hu Z, Du G, Zhang J, Dong Q, Fu F, Tian J.J Ethnopharmacol. 2012 Dec 18;144(3):683-91. doi: 10.1016/j.jep.2012.10.013. Epub 2012 Oct 13.

  • 7. 11C-Hydroxytryptophan Uptake and Metabolism in Endocrine and Exocrine Pancreas.

    Di Gialleonardo V, Signore A, Scheerstra EA, Visser AK, van Waarde A, Dierckx RA, de Vries EF.J Nucl Med. 2012 Nov;53(11):1755-63. doi: 10.2967/jnumed.112.104117. Epub 2012 Sep 21.

  • 8. A novel paramagnetic substrate for detecting myeloperoxidase activity in vivo.

    Shazeeb MS, Xie Y, Gupta S, Bogdanov AA Jr.Mol Imaging. 2012 Sep-Oct;11(5):433-43.

  • 9. Delayed action of serotonin in molluscan development.

    Voronezhskaya EE, Khabarova MY, Nezlin LP, Ivashkin EG.Acta Biol Hung. 2012;63 Suppl 2:210-6. doi: 10.1556/ABiol.63.2012.Suppl.2.28.

  • 10. Ferulic acid potentiates pentobarbital-induced sleep via the serotonergic system.

    Tu Y, Cheng SX, Sun HT, Ma TZ, Zhang S.Neurosci Lett. 2012 Sep 13;525(2):95-9. doi: 10.1016/j.neulet.2012.07.068. Epub 2012 Aug 7.

  • 11. 5-HTP efficacy and contraindications.

    Hinz M, Stein A, Uncini T.Neuropsychiatr Dis Treat. 2012;8:323-8. doi: 10.2147/NDT.S33259. Epub 2012 Jul 19.

  • 12. Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

    Abdala-Valencia H, Berdnikovs S, McCary CA, Urick D, Mahadevia R, Marchese ME, Swartz K, Wright L, Mutlu GM, Cook-Mills JM.Am J Physiol Lung Cell Mol Physiol. 2012 Oct 15;303(8):L642-60. doi: 10.1152/ajplung.00406.2011. Epub 2012 Jul 27.

  • 13. Long-term follow-up of tetrahydrobiopterin therapy in patients with tetrahydrobiopterin deficiency in Japan.

    Shintaku H, Ohwada M.Brain Dev. 2012 Jul 23. [Epub ahead of print]

  • 14. Role of endothelial AADC in cardiac synthesis of serotonin and nitrates accumulation.

    Rouzaud-Laborde C, Hanoun N, Baysal I, Rech JS, Mias C, Calise D, Sicard P, Frugier C, Seguelas MH, Parini A, Pizzinat N.PLoS One. 2012;7(7):e34893. doi: 10.1371/journal.pone.0034893. Epub 2012 Jul 19.

  • 15. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia.

    Opladen T, Hoffmann GF, Blau N.J Inherit Metab Dis. 2012 Nov;35(6):963-73. doi: 10.1007/s10545-012-9506-x. Epub 2012 Jun 23.

  • 16. Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review.

    Baraldi S, Hepgul N, Mondelli V, Pariante CM.J Clin Psychopharmacol. 2012 Aug;32(4):531-43. doi: 10.1097/JCP.0b013e31825d9982. Review.

  • 17. Monitoring lysin motif-ligand interactions via tryptophan analog fluorescence spectroscopy.

    Petrovi? DM, Leenhouts K, van Roosmalen ML, Kleinjan F, Broos J.Anal Biochem. 2012 Sep 15;428(2):111-8. doi: 10.1016/j.ab.2012.06.009. Epub 2012 Jun 17.

  • 18. Identification of isomeric 5-hydroxytryptophan- and oxindolylalanine-containing peptides by mass spectrometry.

    Todorovski T, Fedorova M, Hoffmann R.J Mass Spectrom. 2012 Apr;47(4):453-9. doi: 10.1002/jms.2058.

  • 19. Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts.

    Chen D, Liu Y, He W, Wang H, Wang Z.J Huazhong Univ Sci Technolog Med Sci. 2012 Jun;32(3):422-7. doi: 10.1007/s11596-012-0073-z. Epub 2012 Jun 9.

  • 20. Induction of glucose intolerance by acute administration of rimonabant.

    Mandhane S, Nayak P, Soni D, Jain S, Ashton JC, Rajamannar T.Pharmacology. 2012;89(5-6):339-47. doi: 10.1159/000337731.

Back to top
  • About Us
  • Terms & Conditions
  • Sitemap
  • Contact Us
  • Friendlink
  • Products
Logo of Plant Ingredient
Copyright © 1994-2013 Stanford Chemicals, All Rights Reserved.